Dr. Katrin Leadley has been named chief medical officer of JenaValve Technology, a cardiac medical device company, effective immediately.
Leadley named CMO of JenaValve
In the newly created position, Leadley will work on developing the Wilmington, Del., and Munich-based firm’s transcatheter aortic-valve implantation systems, according to a JenaValve news release. Leadley spent the past seven years at Boston Scientific Corp. and served most recently as global senior medical director of clinical sciences. She was previously director of clinical affairs at Advanced Stent Technologies, Pleasanton, Calif., which Boston Scientific acquired in 2005. Leadley's age was unavailable at deadline.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.